Image

Acalabrutinib Real World Italian obSErvational Study -ARISE

ARISE: Italian study observing Acalabrutinib in real-world use.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Chronic lymphocytic leukemia (CLL) is a type of blood cancer that is common in adults. The ARISE study is looking at acalabrutinib, a medicine used to treat CLL, in a real-world setting in Italy. Acalabrutinib is a drug that blocks a specific protein in cancer cells, helping to stop their growth.

This study is non-interventional, meaning it observes patients without changing their treatment. It will follow patients who started taking acalabrutinib between May 2021 and April 2022, for up to 5 years. The goal is to understand why and when patients stop taking the medicine. Doctors will collect data from patients' medical records.

  • The study follows patients for a maximum of 72 months (6 years).
  • Patients must have started acalabrutinib treatment between May 2021 and April 2022.
  • Doctors will use patient records to collect data; no extra visits are needed.

To join, patients need to be over 18, have CLL, and have started treatment within the specified dates. They also need to agree to share their medical data. This study helps us understand how acalabrutinib works in everyday life.

Print
Study details
    Chronic Lymphocytic Leukemia

NCT06205498

AstraZeneca

24 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.